Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis Treatment Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Psoriatic Arthritis Treatment Drugs by Type
    • 1.3.1 Overview: Global Psoriatic Arthritis Treatment Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Psoriatic Arthritis Treatment Drugs Consumption Value Market Share by Type in 2024
    • 1.3.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
    • 1.3.4 Corticosteroids
    • 1.3.5 Disease-modifying Anti-rheumatic Drugs (DMARDs)
    • 1.3.6 Others
  • 1.4 Global Psoriatic Arthritis Treatment Drugs Market by Application
    • 1.4.1 Overview: Global Psoriatic Arthritis Treatment Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Psoriatic Arthritis Treatment Drugs Market Size & Forecast
  • 1.6 Global Psoriatic Arthritis Treatment Drugs Market Size and Forecast by Region
    • 1.6.1 Global Psoriatic Arthritis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Psoriatic Arthritis Treatment Drugs Market Size by Region, (2020-2031)
    • 1.6.3 North America Psoriatic Arthritis Treatment Drugs Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Psoriatic Arthritis Treatment Drugs Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size and Prospect (2020-2031)
    • 1.6.6 South America Psoriatic Arthritis Treatment Drugs Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Eli Lilly
    • 2.1.1 Eli Lilly Details
    • 2.1.2 Eli Lilly Major Business
    • 2.1.3 Eli Lilly Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.1.4 Eli Lilly Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Eli Lilly Recent Developments and Future Plans
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.2.4 Roche Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Roche Recent Developments and Future Plans
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.3.4 Merck Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck Recent Developments and Future Plans
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.4.4 Novartis Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novartis Recent Developments and Future Plans
  • 2.5 Abbvie
    • 2.5.1 Abbvie Details
    • 2.5.2 Abbvie Major Business
    • 2.5.3 Abbvie Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.5.4 Abbvie Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Abbvie Recent Developments and Future Plans
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.6.4 Amgen Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Amgen Recent Developments and Future Plans
  • 2.7 Bristol Myers Squibb
    • 2.7.1 Bristol Myers Squibb Details
    • 2.7.2 Bristol Myers Squibb Major Business
    • 2.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.7.4 Bristol Myers Squibb Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Bristol Myers Squibb Recent Developments and Future Plans
  • 2.8 Celgene Corporation
    • 2.8.1 Celgene Corporation Details
    • 2.8.2 Celgene Corporation Major Business
    • 2.8.3 Celgene Corporation Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.8.4 Celgene Corporation Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Celgene Corporation Recent Developments and Future Plans
  • 2.9 Janssen
    • 2.9.1 Janssen Details
    • 2.9.2 Janssen Major Business
    • 2.9.3 Janssen Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.9.4 Janssen Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Janssen Recent Developments and Future Plans
  • 2.10 Bausch Health
    • 2.10.1 Bausch Health Details
    • 2.10.2 Bausch Health Major Business
    • 2.10.3 Bausch Health Psoriatic Arthritis Treatment Drugs Product and Solutions
    • 2.10.4 Bausch Health Psoriatic Arthritis Treatment Drugs Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Bausch Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Psoriatic Arthritis Treatment Drugs Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Psoriatic Arthritis Treatment Drugs by Company Revenue
    • 3.2.2 Top 3 Psoriatic Arthritis Treatment Drugs Players Market Share in 2024
    • 3.2.3 Top 6 Psoriatic Arthritis Treatment Drugs Players Market Share in 2024
  • 3.3 Psoriatic Arthritis Treatment Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Psoriatic Arthritis Treatment Drugs Market: Region Footprint
    • 3.3.2 Psoriatic Arthritis Treatment Drugs Market: Company Product Type Footprint
    • 3.3.3 Psoriatic Arthritis Treatment Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Psoriatic Arthritis Treatment Drugs Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Psoriatic Arthritis Treatment Drugs Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Psoriatic Arthritis Treatment Drugs Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Psoriatic Arthritis Treatment Drugs Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Psoriatic Arthritis Treatment Drugs Consumption Value by Type (2020-2031)
  • 6.2 North America Psoriatic Arthritis Treatment Drugs Market Size by Application (2020-2031)
  • 6.3 North America Psoriatic Arthritis Treatment Drugs Market Size by Country
    • 6.3.1 North America Psoriatic Arthritis Treatment Drugs Consumption Value by Country (2020-2031)
    • 6.3.2 United States Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Psoriatic Arthritis Treatment Drugs Consumption Value by Type (2020-2031)
  • 7.2 Europe Psoriatic Arthritis Treatment Drugs Consumption Value by Application (2020-2031)
  • 7.3 Europe Psoriatic Arthritis Treatment Drugs Market Size by Country
    • 7.3.1 Europe Psoriatic Arthritis Treatment Drugs Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 7.3.3 France Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Psoriatic Arthritis Treatment Drugs Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Psoriatic Arthritis Treatment Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Psoriatic Arthritis Treatment Drugs Consumption Value by Region (2020-2031)
    • 8.3.2 China Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 8.3.5 India Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Psoriatic Arthritis Treatment Drugs Consumption Value by Type (2020-2031)
  • 9.2 South America Psoriatic Arthritis Treatment Drugs Consumption Value by Application (2020-2031)
  • 9.3 South America Psoriatic Arthritis Treatment Drugs Market Size by Country
    • 9.3.1 South America Psoriatic Arthritis Treatment Drugs Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Psoriatic Arthritis Treatment Drugs Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Psoriatic Arthritis Treatment Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Psoriatic Arthritis Treatment Drugs Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Psoriatic Arthritis Treatment Drugs Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Psoriatic Arthritis Treatment Drugs Market Drivers
  • 11.2 Psoriatic Arthritis Treatment Drugs Market Restraints
  • 11.3 Psoriatic Arthritis Treatment Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Psoriatic Arthritis Treatment Drugs Industry Chain
  • 12.2 Psoriatic Arthritis Treatment Drugs Upstream Analysis
  • 12.3 Psoriatic Arthritis Treatment Drugs Midstream Analysis
  • 12.4 Psoriatic Arthritis Treatment Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Psoriatic Arthritis Treatment Drugs market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Psoriatic Arthritis Treatment Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Psoriatic Arthritis Treatment Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Psoriatic Arthritis Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Psoriatic Arthritis Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Psoriatic Arthritis Treatment Drugs market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Psoriatic Arthritis Treatment Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Psoriatic Arthritis Treatment Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Roche, Merck, Novartis, Abbvie, Amgen, Bristol Myers Squibb, Celgene Corporation, Janssen, Bausch Health, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Psoriatic Arthritis Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
    Corticosteroids
    Disease-modifying Anti-rheumatic Drugs (DMARDs)
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Market segment by players, this report covers
    Eli Lilly
    Roche
    Merck
    Novartis
    Abbvie
    Amgen
    Bristol Myers Squibb
    Celgene Corporation
    Janssen
    Bausch Health
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Psoriatic Arthritis Treatment Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Psoriatic Arthritis Treatment Drugs, with revenue, gross margin, and global market share of Psoriatic Arthritis Treatment Drugs from 2020 to 2025.
    Chapter 3, the Psoriatic Arthritis Treatment Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Psoriatic Arthritis Treatment Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Psoriatic Arthritis Treatment Drugs.
    Chapter 13, to describe Psoriatic Arthritis Treatment Drugs research findings and conclusion.

    Buy now